Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X

CAS 3381-48-4 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 3381-48-4
Also known as: 3381-48-4, N-(4-fluorophenyl)-1-(4-methoxyphenyl)methanimine, Schembl2904627, Zinc96460, Dtxsid10351732, Stk070800
Molecular Formula
C14H12FNO
Molecular Weight
229.25  g/mol
InChI Key
ZICFPEHQRZAFBZ-UHFFFAOYSA-N

1 2D Structure

CAS 3381-48-4

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-(4-fluorophenyl)-1-(4-methoxyphenyl)methanimine
2.1.2 InChI
InChI=1S/C14H12FNO/c1-17-14-8-2-11(3-9-14)10-16-13-6-4-12(15)5-7-13/h2-10H,1H3
2.1.3 InChI Key
ZICFPEHQRZAFBZ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
COC1=CC=C(C=C1)C=NC2=CC=C(C=C2)F
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 3381-48-4

2. N-(4-fluorophenyl)-1-(4-methoxyphenyl)methanimine

3. Schembl2904627

4. Zinc96460

5. Dtxsid10351732

6. Stk070800

7. Akos000344077

8. 4-fluorophenyl(4-methoxybenzylidene)-amine

9. N-(4-methoxybenzylidene)-4-fluoroaniline, 97%

10. J-019330

11. 4-fluoro-n-[(e)-(4-methoxyphenyl)methylidene]aniline

2.3 Create Date
2005-07-08
3 Chemical and Physical Properties
Molecular Weight 229.25 g/mol
Molecular Formula C14H12FNO
XLogP33.3
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count3
Rotatable Bond Count3
Exact Mass229.090292168 g/mol
Monoisotopic Mass229.090292168 g/mol
Topological Polar Surface Area21.6 Ų
Heavy Atom Count17
Formal Charge0
Complexity241
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
70627-52-0
Ezetimibe
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few ...
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few years, Malladi established itself as a leader in manufacturing ephedrine and pseudoephedrine salts. Today, it is the leading manufacturer of APIs in the cough and cold segment. It also has a dominant presence in several therapeutic segments like antihistamines, anti-convulsants, anti-depressants and anxiolytics (CNS). Malladi exports its products to around 60 countries and over 85% of its revenue is generated from exports. Its manufacturing facilities have been approved by the FDA, EDQM, KFDA, TGA and various other regulatory agencies.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY